James Tobin, Director at TransMedics Group, holds 180.13K shares in TransMedics Group (Ticker: TMDX), holds ― shares in Lyra Therapeutics (Ticker: LYRA), holds 144.92K shares in Curis (Ticker: CRIS).
James Tobin latest transaction was an Uninformative Buy of ―.
What was James Tobin's most profitable transaction?
James Tobin’s most profitable transaction was an Informative Sell of TMDX stock on August 9, 2024. The return on the trade was 29.70%.
What is James Tobin's role in TransMedics Group?
James Tobin's role in TransMedics Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.